Register
Login:
Share:
Email Facebook Twitter


Angus Energy announces transformational joint venture with Cuadrilla & Lucas Energy
Aim-listed Mongolian explorer Petro Matad to drill four wells in 2018


Angle Share Price (AGL)



Share Price Information for Angle (AGL)


Share Price: 48.75Bid: 48.00Ask: 49.50Change: 0.00 (0.00%)No Movement on Angle
Spread: 1.50Spread as %: 3.13%Open: 48.75High: 48.75Low: 48.75Yesterday’s Close: 48.75

Angle Plc Ord 10P

Angle is listed in the FTSE AIM All-Share
Angle is part of the Support sector






Share Price SpacerPrice
48.75

Share Price SpacerBid
48.00

Share Price SpacerAsk
49.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
20,334

Share Price SpacerOpen
48.75

Share Price SpacerHigh
48.75

Share Price SpacerLow
48.75

Share Price SpacerClose
48.75

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 117.09m £57.08m 3,000

52 Week High 80.00 52 Week High Date 15-JUN-2017
52 Week Low 32.25 52 Week Low Date 8-SEP-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
5 3,200 17,134 -5.597 -8.71 0.00 0.00


London South East Users info for Angle




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

16-Feb-18
09:51:37
49.00
314,211
Buy* 
48.00
49.50
153.96k
Trade Type:
Ordinary
Delayed publication

16-Feb-18
09:51:57
49.00
325,000
Buy* 
48.00
49.50
159.25k
Trade Type:
Ordinary
Delayed publication

16-Feb-18
16:17:07
48.90
6,134
Buy* 
48.00
49.50
3,000
Trade Type:
Ordinary




View more Angle trades >>

Directors Deals for Angle (AGL)
Trade DateActionNotifierPriceCurrencyAmountHolding
26-Oct-16Buy
Trade Notifier Information for Angle
Andrew D Newland held the position of CEO at Angle at the time of this trade.
 Andrew D Newland
57GBX1,350,0007054686
30-Apr-16Notification of Holding
Trade Notifier Information for Angle
Ian F Griffiths held the position of Finance Director at Angle at the time of this trade.
 Ian F Griffiths
00559546
30-Apr-16Notification of Holding
Trade Notifier Information for Angle
Garth Selvey held the position of Chairman at Angle at the time of this trade.
 Garth Selvey
0020000
View more Angle directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 18:44Dibs61boom48.75Buy
Thanks. Yes, and although it£s an overused word on AIM 2018 really could be the £transformational£ year for Angle.

For me the key thing is they still have the competitive advantage through harvesting CTC£s that no other liquid biopsy product can do. Plus they are now forming potentially highly valuable partnerships with industry heavyweights.
11 Feb '18boomorbustRE: FDA clearance48.00No Opinion
Dibs, as primary completion date is scheduled for June, I assume recruitment will be very quick. As far as I know, the trial can commence as soon as the first patient consents, they don't have to wait until all patients have been recruited.

Really looking forward to seeing how the trial goes and if successful what an achievement this will be for an AIM bio:-

"ANGLE is seeking to become the first company ever to receive FDA clearance for a medical device to harvest cancer cells from… Read More
11 Feb '18Dibs61Sorry!48.00No Opinion
400 patients - 200 MBC and 200 healthy
11 Feb '18Dibs61RE: FDA clearance48.00No Opinion
boom -yep good find and good news. I notice the status is £not yet recruiting£. I£m postulating how long it will take to recruit the stipulated 200 patients. Also, can the trial actually commence before all 200 are recruited?

I am certainly very positive about the outcome given Parsortix performance to date.
10 Feb '18MissBMWRE : FDA clearance48.00No Opinion
Boom, excellent news. You certainly do well to find this information. Thanks for sharing here. Looks like if it drifts into H2 it won't be by much.
10 Feb '18boomorbustFDA clearance48.00No Opinion
Breast cancer trial has now appeared on the Clinical Trials Register. Start date is Feb, so any day now and primary completion date is June. It seems to have been a long time coming and good to see it finally there in black and white.

https://clinicaltrials.gov/ct2/show/NCT03427450?term=parsortix&rank=1

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Angle (AGL) >>

Please login or register to post a message on Share Chat.





Angle Plc Ord 10P home pageWebsite: Angle Plc Ord 10P
Website Description: ANGLEplc.com



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.